Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy
Grantová podpora
R33 HL157069
NHLBI NIH HHS - United States
P01 HL103455
NHLBI NIH HHS - United States
U54 NS127758
NINDS NIH HHS - United States
R35 ES030443
NIEHS NIH HHS - United States
P42 ES004699
NIEHS NIH HHS - United States
Z01 ES025034
Intramural NIH HHS - United States
Wellcome Trust - United Kingdom
R01 GM125944
NIGMS NIH HHS - United States
R01 HL132550
NHLBI NIH HHS - United States
R35 GM139641
NIGMS NIH HHS - United States
S10 OD032141
NIH HHS - United States
S10 OD023402
NIH HHS - United States
PubMed
40392938
PubMed Central
PMC12330888
DOI
10.1126/scisignal.adw1245
Knihovny.cz E-zdroje
- MeSH
- chromatografie kapalinová metody MeSH
- hmotnostní spektrometrie * metody MeSH
- kapalinová chromatografie-hmotnostní spektrometrie MeSH
- lidé MeSH
- lipidomika * metody MeSH
- oxylipiny * analýza MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- oxylipiny * MeSH
Several oxylipins are potent lipid mediators that regulate diverse aspects of health and disease and whose quantitative analysis by liquid chromatography-mass spectrometry (LC-MS) presents substantial technical challenges. As members of the lipidomics community, we developed technical recommendations to ensure best practices when quantifying oxylipins by LC-MS.
Applied Analytical Chemistry University of Duisburg Essen Essen Germany
Cayman Chemical Company Ann Arbor MI USA
Centers for Disease Control and Prevention Atlanta GA USA
Centre for Metabolomics and Bioanalysis Faculty of Pharmacy CEU San Pablo University Madrid Spain
College of Health and Life Sciences Hamad Bin Khalifa University Doha Qatar
Core Facility Mass Spectrometry ZMF Medical University of Graz Graz Austria
Department of Analytical Chemistry University of Valencia Burjassot Spain
Department of Analytical Chemistry University of Vienna Vienna Austria
Department of Biochemistry Institute of Chemistry University of São Paulo São Paulo Brazil
Department of Chemistry and Biochemistry Concordia University Montreal Canada
Department of Chemistry and Industrial Chemistry University of Pisa Pisa Italy
Department of Chemistry University of Aveiro Aveiro Portugal
Department of Chemistry University of Washington Seattle WA USA
Department of Entomology University of California Davis CA USA
Department of Food Science and Technology University of California Davis CA USA
Department of Kinesiology and Health Sciences University of Waterloo Waterloo Canada
Department of Pharmacology and Chemical Biology University of Pittsburgh Pittsburgh PA USA
Department of Pharmacology University of Colorado Denver Denver CO USA
Department of Respiratory Medicine and Allergy Karolinska University Hospital Stockholm Sweden
Faculty of Chemical Technology University of Pardubice Pardubice Czech Republic
Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
Fraunhofer Cluster of Excellence of Immune Mediate Diseases CIMD Frankfurt am Main Germany
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP Frankfurt am Main Germany
Health Sciences Mass Spectrometry Core University of Pittsburgh Pittsburgh PA USA
Indigo BioAutomation Carmel IN USA
Institute for Global Food Security Queen's University Belfast Belfast Northern Ireland
Institute of Pharmaceutical Chemistry Goethe University Frankfurt Frankfurt am Main Germany
Leiden University Medical Center Leiden Netherlands
Lipidomics Consulting Ltd Esbo Finland
Long Loo Lin School of Medicine National University of Singapore
Mass Spectrometry Core Facility Department of Chemistry Columbia University New York NY USA
Medical School Royal Perth Hospital Unit University of Western Australia Perth Australia
Neonatal Research Group Health Research Institute La Fe Valencia Spain
RIKEN Center for Integrative Medical Sciences Yokohama Kanagawa Japan
Rowett Institute School of Medicine Medical Science and Nutrition University of Aberdeen Aberdeen UK
School of Biological Sciences Victoria University of Wellington Wellington New Zealand
School of Chemistry and Biochemistry Georgia Institute of Technology Atlanta GA USA
School of Mathematics and Natural Sciences University of Wuppertal Wuppertal Germany
School of Medicine Cardiff University Heath Park Cardiff UK
Zobrazit více v PubMed
Ricciotti E, FitzGerald GA, Aspirin in the Prevention of Cardiovascular Disease and Cancer. Annu Rev Med 72, 473–495 (2021); published online EpubJan 27 ( 10.1146/annurev-med-051019-102940). PubMed DOI
von Euler US, On the specific vasodilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesigIandin). J. Physiol. (Lond. 88, 213 (1936). PubMed PMC
Bergstroem S, Danielsson H, Samuelsson B, The Enzymatic Formation of Prostaglandin E2 from Arachidonic Acid Prostaglandins and Related Factors 32. Biochim Biophys Acta 90, 207–210 (1964); published online EpubJul 15 ( 10.1016/0304-4165(64)90145-x). PubMed DOI
Vane JR, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231, 232–235 (1971); published online EpubJun 23 ( 10.1038/newbio231232a0). PubMed DOI
Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH Jr., Murphy RC, Raetz CR, Russell DW, Seyama Y, Shaw W, Shimizu T, Spener F, van Meer G, VanNieuwenhze MS, White SH, Witztum JL, Dennis EA, A comprehensive classification system for lipids. J Lipid Res 46, 839–861 (2005); published online EpubMay ( 10.1194/jlr.E400004-JLR200). PubMed DOI
Kopczynski D, Ejsing CS, McDonald JG, Bamba T, Baker ES, Bertrand-Michel J, Brugger B, Coman C, Ellis SR, Garrett TJ, Griffiths WJ, Guan XL, Han X, Horing M, Holcapek M, Hoffmann N, Huynh K, Lehmann R, Jones JW, Kaddurah-Daouk R, Kofeler HC, Meikle PJ, Metz TO, O’Donnell VB, Saigusa D, Schwudke D, Shevchenko A, Torta F, Vizcaino JA, Welti R, Wenk MR, Wolrab D, Xia Y, Ekroos K, Ahrends R, Liebisch G, The Lipidomics Reporting Checklist A framework for transparency of lipidomic experiments and repurposing resource data. J Lipid Res, 100621 (2024); published online EpubAug 14 ( 10.1016/j.jlr.2024.100621). PubMed DOI PMC
Liebisch G, Ekroos K, Hermansson M, Ejsing CS, Reporting of lipidomics data should be standardized. Biochim Biophys Acta Mol Cell Biol Lipids 1862, 747–751 (2017); published online EpubAug ( 10.1016/j.bbalip.2017.02.013). PubMed DOI
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): ICH guideline M10 on bioanalytical method validation and study sample analysis (2022).
Bioanalytical Method Validation Guidance for Industry, FDA/CDER/CVM 2001 (2018).
Lynch KL, CLSI C62-A: A New Standard for Clinical Mass Spectrometry. Clin Chem 62, 24–29 (2016); published online EpubJan ( 10.1373/clinchem.2015.238626). PubMed DOI